Goserelin implant - NovalonAlternative Names: Zoreline®
Latest Information Update: 23 Feb 2017
At a glance
- Originator Novalon
- Class Antineoplastics; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Endometriosis; Prostate cancer
Most Recent Events
- 23 Feb 2017 Chemical structure information added